Evidence map›Paper›PMID 41231872›Full record

ArticlePloS one2025

Association of socioeconomic disadvantage with operative outcomes for infective endocarditis.

Barzin Badiee, Sara Sakowitz, Saad Mallick, Nguyen Le, Arjun Chaturvedi, Kevin Tabibian, Esteban Aguayo, Peyman Benharash

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Barzin BadieeCardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Sara SakowitzCardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Saad MallickCardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Nguyen LeCardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Arjun ChaturvediCardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Kevin TabibianCardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Esteban AguayoCardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Peyman BenharashCardiovascular Outcomes Research Laboratories (CORELAB), David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.ORCID https://orcid.org/0000-0002-4705-0262

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSocial determinants of health (SDOH) are well-recognized contributors of disparities in cardiovascular disease. Yet, the association of socioeconomic disadvantage with outcomes following operative management of infectious endocarditis (IE) remains ill-defined.

methodsNonelective adult (≥18 years) hospitalizations entailing cardiac valve operations for IE were tabulated from the 2016-2021 Nationwide Readmissions Database. Those facing adverse SDOH, including compromised economic, educational, healthcare, environmental, and social conditions, were categorized as Disadvantaged (others: Non-Disadvantaged). Multivariable regression models were developed to examine the association of socioeconomic disadvantage with key endpoints.

resultsOf an estimated 36,527 hospitalizations, 31.9% were categorized as Disadvantaged with the proportion increasing from 27.0% in 2016 to 34.8% in 2021 (P < 0.001). On average, Disadvantaged was younger (50 [34-64] vs 53 years [37-65], P < 0.001), more frequently insured by Medicaid (33.8 vs 26.4%, P < 0.001), and more commonly underwent isolated tricuspid operations (21.9 vs 13.7%, P < 0.001). Following risk adjustment, Disadvantage remained linked with significantly greater likelihood of acute kidney injury (Adjusted Odds Ratio [AOR] 1.20, 95% Confidence Interval [CI] 1.12-1.29), stroke (AOR 1.25, 95%CI 1.11-1.41), and prolonged mechanical ventilation ≥24 hours (AOR 1.80, 95%CI 1.65-1.96). Further, Disadvantaged was associated with incremental increases in postoperative hospitalization duration (+4.97 days, 95%CI 4.39-5.54) and costs (+$32,900, 95%CI $29,300-36,500) as well as a greater risk of nonelective 90-day readmissions (AOR 1.12, 95%CI 1.03-1.23).

conclusionsAdverse SDOH are independently linked with greater morbidity and resource utilization following surgical management of IE. Efforts are needed to ensure comprehensive SDOH screening upon admission and develop targeted in-hospital interventions to address persistent disparities.

Indexed as

EndocarditisAdultAgedFemaleHealthcare DisparitiesHospitalizationHumansMaleMiddle AgedPatient ReadmissionSocial Determinants of HealthSocioeconomic Disparities in HealthSocioeconomic FactorsTreatment OutcomeUnited States

Identifiers

PMID41231872
PMCPMC12614508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.